Depomed Inc $11.74

down -0.03


25/7/2014 04:00 PM  |  NASDAQ : DEPO  
Industries : Drugs / Drug Manufacturers - Other
Get Trend Analysis Icon Get DEPO Trend Analysis - it has outperformed the S&P 500 by 74%

Partner Headlines

  1. Depomed May Be Setting Up In A New Base

    IBD
  2. Depomed A 'Turtle' Gaining In Specialty Pharma Race

    IBD
  3. Top 4 Small-Cap Stocks In The Drug Manufacturers-Other Industry With The ...

    Benzinga
  4. Mid-Day Market Update: Stocks Turn Mostly Lower; VeriFone Shares Fall On ...

    Benzinga
  5. UPDATE: JMP Securities Reiterates on Depomed Following Acquisition of Migraine ...

    Benzinga
  6. Depomed Acquires US Rights to CAMBIA Migraine Medicine from Nautilus Neurosciences ...

    Benzinga
  7. UPDATE: Depomed Sells Type 2 Diabetes Royalties And Milestones To PDL BioPharma ...

    Benzinga
  8. Depomed Announces Acquisition Of Lazanda® (fentanyl) Nasal Spray From Archimedes ...

    Benzinga
  9. Depomed Inc. Reports Operating Results (10-Q)

    GuruFocus
  10. Depomed Appoints Dr. Samuel Saks To Its Board Of Directors

    Benzinga
  11. Breeze 3 data for Serada presented at 2012 North American Menopause Society ...

    Benzinga
  12. Depomed Files Suit Against The FDA Seeking Grant Of Orphan Drug Exclusivity ...

    Benzinga
  13. Depomed Inc. Reports Operating Results (10-Q)

    GuruFocus
  14. Depomed Announces Publication of Phase 3 Data from Gralise® (gabapentin) ...

    Benzinga
  15. IHS, Ebix Included in Stocks Up on High Volume Friday

    FoxBusiness
  16. Depomed Announces Acquisition Of Zipsor From Xanodyne Pharmaceuticals, ...

    Benzinga
  17. Depomed Announces Issuance of Formulation Patent Covering Gralise® (gabapentin)

    Benzinga
  18. Earnings Scheduled For May 8

    Benzinga
  19. A Peek Into The Market Before The Trading Starts

    Benzinga
  20. Benzinga's Top Pre-Market Gainers

    Benzinga
  21. Depomed Announces FDA Approval of Merck's JANUMET XR That Accesses Depomed ...

    Benzinga
  22. Depomed Receives Notice of Paragraph IV Certification Against Patents for ...

    Benzinga
  23. Options Players Gravitate Toward Depomed Puts

    SchaeffersResearch
Trading Center